Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria
Clinical trial NCT00525382 · COMPLETED
Trial details
- NCT number
- NCT00525382
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2004-03-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.